Vectura Share Discussion Threads

[polaris] 21/10/2019 15:54

In terms of revenue possibilities, Advair generic is a non-event for me. It is going to be worth a few $m in royalties at best, if it makes it to launch. Of more relevance are the developments wrt generic Ellipta and the approval decision on QVM149, which is likely to be market competition for Trelegy.

I think this week is the last real opportunity for the short term traders to turn a buck. Next week the DRIP will kick in alongside the buyback. The mandate there is an average of 80k shares per day for the 6-month period, assuming a flat share price

Expect share capital to be around 595M by the end of 2020, with cash in hand as high as $210M by that date.

Assuming all outstanding cash is finally paid to VEC by GSK then R&D is fully funded for the next 4 years from cash in hand - timescale for commercial approval of the Ellipta generics.

[dp1umb] 21/10/2019 15:41

Or leaked advair news

[frazboy] 21/10/2019 12:01

Andrew - I would imagine a broker reduce/sell note.. that's very speculative thoVolume seems to have dropped off for now

[pooroldboy55] 21/10/2019 11:55

Normanly when a share falls like this something wrong ,and its not because im back from holiday
Edit
Re buy back well at lest they will be able to buy more.

[gbcol] 21/10/2019 11:49

I've also taken opportunity of share price dip to buy some back this morning (from upcoming divi) but can only get max £1000 online at the moment, presumably meaning there isn't much stock around (any other view on this). Also bought some more last week. Would like to get a few more but more than happy to see the share price start climbing again.

I wonder if buyback will commence today (can't remember if there was a set start date)

EDIT : Share buyback actually due to commence 30 October 19

[pooroldboy55] 21/10/2019 10:29

Best of luck Paul but VEC do look headless at the moment .Yes the BOD are doing a great job share price no better than 6 years ago and going down, as i say PAUL best of luck you must be a lot younger than me at this rate i will be pushing up daisies before this comes good.
Cheers Andrew
Edit
To me and i could well be wrong normally am this looks like someone knows something down almost 6p fri/mon and for us decent numbers.

[polaris] 21/10/2019 10:14

I've taken another 15k this morning. Effectively, reinvested the dividend.

[pooroldboy55] 21/10/2019 09:54

Looks like the BOD plan to get the price up working well,

[frazboy] 21/10/2019 09:53

Quite a sharp sell off taking place. Belated reaction to the fact that Vectura is a foreign earner and thus FX related earnings pressure? Or something else?

[base7] 19/10/2019 10:09

Buy back can help stabilise & support our share price ,particularly if we continue rising following positive news (Advair generic ,progress on Ellipta generic,new product developments ,new CEO appointment .confirmation that GSK will settle amount due .Plus second buy back of $10mill to be activated ,if required

[alexchry] 18/10/2019 16:07

polaris, the share buyback is only £10M initially and for up to six months so any effect on shareholdings or trading patterns is likely to be slow and small.

[jimboyce] 18/10/2019 15:09

Yes I follow. Thanks.

[polaris] 18/10/2019 15:06

After consolidation yes but the buyback and cancellation will reduce the current 615M or so shares down to below 600M. That will change holdings for all.

[jimboyce] 18/10/2019 14:53

I understood that the ownership % would remain the same. Please explain.

[polaris] 18/10/2019 14:23

A sideline for the upcoming buyback is that total number of shares will fall meaning some major holders cross %age thresholds requiring an RNS. That may also clear up some of the trading patterns. £10M will buy around 11.5M shares and there is also the second mandated £10M.

[dp1umb] 17/10/2019 17:57

Yes and this is against a backdrop of a stronger sterling and two major holders offloading

[brucie5] 17/10/2019 10:28

Look like the cusp of the long awaited breakout. Just needs to break 90p... Otherwise, rinse and repeat.

[fhmktg] 16/10/2019 16:05

CRL response expected Q4 2019 according to the last update, so still lots of time to wait!

[base7] 16/10/2019 14:12

If we are hoping to launch next year I would have thought news from HIK/Vec regarding our Advair generic should be imminent ?

[davr0s] 14/10/2019 18:47

Share price basing - I'm in positive territory here. Lot of negativity here - why do people continue holding if they have such a negative view - just sell up and move on

[best1467] 14/10/2019 18:40

So You were one of the other two PI investors who Attended or were you there as paid employee may be.But the comments from the poster who also attended when asked for a breakdown of the Ono to one conversations he had very little to tell or maybe he did but chose not to share on this board.
We are currently drifting along like a rudderless ship with mutiny amongst the deck hands with no direction.

[cottonpickers] 14/10/2019 17:14

Buyback starts around 30th with a £10m allocation over first 6months. So although it could be the buyback I suspect it isn't.

[kolosos] 14/10/2019 17:07

That end of day trade is the start of the buyback in the open market ?

[cockneytrader] 14/10/2019 15:15

Will GSK appeal? My understanding is the time limit for appeal is 30 days (or 60 days for government agency). If so, the 30 days have passed.